| MeSH term | MeSH ID | Detail |
|---|---|---|
| Precancerous Conditions | D011230 | 48 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Osteosarcoma | D012516 | 50 associated lipids |
| Thyroid Neoplasms | D013964 | 33 associated lipids |
| Leukemia, Myeloid, Acute | D015470 | 19 associated lipids |
| HIV Infections | D015658 | 20 associated lipids |
| Head Injuries, Closed | D016489 | 5 associated lipids |
| Anisakiasis | D017129 | 2 associated lipids |
| Dermatitis, Allergic Contact | D017449 | 20 associated lipids |
| Nerve Sheath Neoplasms | D018317 | 4 associated lipids |
2E,6E-farnesol
2e,6e-farnesol is a lipid of Prenol Lipids (PR) class. 2e,6e-farnesol is associated with abnormalities such as Granulomatous Disease, Chronic, pathologic fistula and Cavitation. The involved functions are known as Regulation, Metabolic Inhibition, cholesterol biosynthetic process, Process and Transcription, Genetic. 2e,6e-farnesol often locates in Plasma membrane, Cytoplasmic matrix, cornified envelope, Epidermis and peroxisome. The associated genes with 2E,6E-farnesol are RAB3A gene, FOSL1 gene, CASP8AP2 gene, RCC1 gene and GALE gene. The related lipids are Sterols, Membrane Lipids and Steroids.
Cross Reference
Introduction
To understand associated biological information of 2E,6E-farnesol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 2E,6E-farnesol?
2E,6E-farnesol is suspected in Granulomatous Disease, Chronic, pathologic fistula and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2E,6E-farnesol
PubChem Associated disorders and diseases
What pathways are associated with 2E,6E-farnesol
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 2E,6E-farnesol?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 2E,6E-farnesol?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 2E,6E-farnesol?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 2E,6E-farnesol?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 2E,6E-farnesol?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 2E,6E-farnesol
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Suzue G et al. | Presence of squalene in Staphylococcus. | 1968 | Arch. Biochem. Biophys. | pmid:5650319 |
| Dorsey JK and Porter JW | The inhibition of mevalonic kinase by geranyl and farnesyl pyrophosphates. | 1968 | J. Biol. Chem. | pmid:4300840 |
| Masner P et al. | Sexually spread insect sterility induced by the analogues of juvenile hormone. | 1968 | Nature | pmid:5690848 |
| Ortone G and Furno F | [Gefarnate in the therapy of peptic ulcer]. | 1968 | Minerva Med. | pmid:5707471 |
| Gefarnate. | 1968 | Drug Ther Bull | pmid:5722353 | |
| Mincis M | [Clinical study of the effect of geranyl of farnesylacetate combined with nafiver in peptic ulcer patients]. | 1968 | Rev Bras Med | pmid:5724217 |
| Cesco G | [Geranyl farnesylacetate as a preventive and therapeutic agent in disorders of the digestive system caused by corticoids]. | 1967 Oct-Dec | Minerva Gastroenterol | pmid:5607545 |
| Da Grada CT et al. | [Endoscopic study of clinical trials of geranyl farnesylacetate]. | 1967 Oct-Dec | Minerva Gastroenterol | pmid:5607546 |
| Egorov IA et al. | [Farnesol in brandy]. | 1967 Mar-Apr | Dokl. Akad. Nauk SSSR | pmid:5623628 |
| Van der Kloot WG | Goals and strategy of comparative pharmacology. | 1967 Jul-Aug | Fed. Proc. | pmid:6028781 |